NASH

What is the NASH?

Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. It is part of a group of conditions called nonalcoholic fatty liver disease. You may be told you have a “fatty liver.” Many people have a buildup of fat in the liver, and for most people it causes no symptoms and no problems. But in some people, the fat causes inflammation and damages cells in the liver. Because of the damage, the liver doesn’t work as well as it should.

NASH can get worse and cause scarring of the liver, which leads to cirrhosis. But the disease doesn’t always get worse.

NASH is similar to the kind of liver disease that is caused by long-term, heavy drinking. But NASH occurs in people who don’t abuse alcohol.

Why a Nash Mission area?

NASH

Recent Posts

The e-SPACE web-conference on Heart Failure will take place on July 11-14, 2020

The e-SPACE web-conference on Heart Failure will take place on July 11-14, 2020

PRESS RELEASEBasel, Swittzerland  –  15 May 2020 To enable the international heart failure community to keep abreast with the latest advances in the field, the Translational Medicine Academy (TMA) is proud to announce the 1st Global web-Conference on Heart Failure.The e-SPACE conference on Heart Failure (HF) will take place in 3 time zones on July 11-14, 2020, and is supported by a […]

Inventiva annonce des nouvelles avancées dans le développement clinique de lanifibranor pour le traitement de la NASH

Daix (France), le 21 février 2019 – Inventiva (Euronext : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de maladies dans les domaines de la fibrose, de la surcharge lysosomale et de l’oncologie, annonce aujourd’hui la sélection du premier patient aux États-Unis pour son étude clinique de Phase […]